Insider · SEC Forms 3, 4, 5
CIK 1494730
All transactions
Every Form 4 row this person reported, newest first
Insider · SEC Forms 3, 4, 5
Every Form 4 row this person reported, newest first
TCG Opportunity III GP, LLC (CIK 1932445) reported 41 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-09-08). Recent activity: Buy EIKN (89,200 shares), Sell TNYA (309,228 shares), Sell TNYA (349,212 shares), Sell TNYA (1.6M shares), Sell TNYA (1.9M shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-08 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 89,200 | $1.0M |
| 2026-02-26 | Tenaya Therapeutics, Inc. (TNYA) | 10% Owner | Sell | 309,228 | $191,721 |
| 2026-02-26 | Tenaya Therapeutics, Inc. (TNYA) | 10% Owner | Sell | 349,212 | $216,511 |
| 2026-02-26 | Tenaya Therapeutics, Inc. (TNYA) | 10% Owner | Sell | 1.6M | $923,597 |
| 2026-02-26 | Tenaya Therapeutics, Inc. (TNYA) | 10% Owner | Sell | 1.9M | $1.0M |
| 2026-02-24 | Tenaya Therapeutics, Inc. (TNYA) | 10% Owner | Sell | 245,965 | $150,039 |
| 2026-02-24 | Tenaya Therapeutics, Inc. (TNYA) | 10% Owner | Sell | 277,769 | $169,439 |
| 2026-02-24 | Tenaya Therapeutics, Inc. (TNYA) | 10% Owner | Sell | 143,709 | $86,225 |
| 2026-02-24 | Tenaya Therapeutics, Inc. (TNYA) | 10% Owner | Sell | 162,291 | $97,375 |
| 2026-02-12 | Tenaya Therapeutics, Inc. (TNYA) | 10% Owner | Sell | 2.2M | $1.5M |
| 2026-02-12 | Tenaya Therapeutics, Inc. (TNYA) | 10% Owner | Sell | 182,295 | $149,482 |
| 2026-02-12 | Tenaya Therapeutics, Inc. (TNYA) | 10% Owner | Sell | 1.9M | $1.3M |
| 2026-02-12 | Tenaya Therapeutics, Inc. (TNYA) | 10% Owner | Sell | 161,422 | $132,366 |
| 2026-02-09 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 1.3M | $0 |
| 2026-02-09 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 1.4M | $0 |
| 2026-02-09 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 110,928 | $0 |
| 2026-02-09 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 44,249 | $0 |
| 2026-02-09 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 47,898 | $0 |
| 2026-02-09 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 3,785 | $0 |
| 2026-02-09 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 688,283 | $0 |
| 2026-02-09 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 1.4M | $25.9M |
| 2026-02-09 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 49,556 | $892,008 |
| 2026-02-09 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 630,881 | $11.4M |
| 2026-01-20 | Surrozen, Inc./DE (SRZN) | 10% Owner | Buy | 5,590 | $111,185 |
| 2026-01-20 | Surrozen, Inc./DE (SRZN) | 10% Owner | Buy | 6,303 | $125,367 |
Source: SEC Form 4 filings · as of 2026-09-08